-
VHSD
Viral Hepatitle Savaşım Derneği
Clin Microbiol Infect. 2015 Jul 7. pii: S1198-743X(15)00690-4. doi: 10.1016/j.cmi.2015.06.028. [Epub ahead of print]
Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: A fieldwork TURHEP study.
Tozun N1, Ozdogan O2, Cakaloglu Y3, Idilman R4, Karasu Z5, Akarca U5, Kaymakoglu S6, Ergonul O7.
Abstract
The present study was designed to determine seroprevalence of Hepatitis B and C virus infections and risk factors in Turkish general population. The subjects were enrolled from urban and rural areas of the predetermined 23 EUROSTAT NUTS 2 region. A two -stage stratified sampling method was used to select participants from these regions. Participants' (n=5460; 50.9% females; mean(SD) age: 40.8(14.7) years) socio-demographics, clinical characteristics and risk factors were recorded at home visits. The seropositivity rates for HBsAg, anti-HCV, anti-HBs and anti-HBc total were found as 4.0%, 1.0%, 31.9%, and 30.6%, respectively. Among HBsAg-positive cases, 94.5% were anti-HBe-positive, 70.2% HBV-DNA-positive, and 2.8 % anti-HDV total positive; 99.1% of HBV subjects were of genotype D. Close contact with hepatitis patient (OR, 3.24; 95% CI, 2.25 to 4.66; p<0.001), living in South-eastern region (OR, 2.74; 95% CI, 1.7 to 4.45; p<0.001), male gender (OR, 1.77; 95% CI, 1.28 to 2.46; p<0.001), being married (OR, 1.62; 95% CI,1.02 to2.57; p=0.038, educational level less than high school (OR, 1.53; 95% CI, 1.04 to 2.26; p=0.03), orodental interventions (OR, 1.54; 95%CI, 1.01 to 2.35; p=0.047) and use of non-disposable syringe history (OR, 1.4; 95% CI, 1.01 to 1.96; p=0.045) were significant determinants of HBsAg positivity. Age?50 years (OR, 2; 95% CI, 1.09 to 4.3; p=0.026) was the only significant predictor of anti-HCV positivity. In conclusion, our findings revealed an HBsAg positivity in 4% and anti-HCV positivity in 1% of adult population and at least 1/3 of the population has been exposed to HBV infection in Turkey.
Copyrights © 2017-2023 All Rights Reserved. Powered by vhsd.org
Kişisel Verilerin Korunması Kanununu
Web sitemizin içeriği, ziyaretçiyi bilgilendirmeye yönelik hazırlanmıştır. Sitede yer alan bilgiler, hiçbir zaman bir hekim tedavisinin ya da konsültasyonunun yerini alamaz. Bu kaynaktan yola çıkarak, ilaç tedavisine başlanması ya da mevcut tedavinin değiştirilmesi kesinlikte tavsiye edilmez. Web sitemizin içeriği, asla kişisel teşhis ya da tedavi yönteminin seçimi için değerlendirilmemelidir. Sitede kanun içeriğine aykırı ilan ve reklam yapma kastı bulunmamaktadır.© 2017 - 2023, Tüm hakları saklıdır. Gizlilik Sözleşmesi. Bu web sitesi CEOTECH tarafından yapılmıştır. Daha detaylı bilgi almak için lütfen tıklayınız.